Loading...
Loading...
Among the 5 tracked institutional investors we monitor, RNA (ATRIUM THERAPEUTICS INC) is held with a combined value of $21.72M across 1,624,313 shares. The largest holder is BlackRock, Inc. with a position worth $16.11M (0.00% of their portfolio). 5 funds opened new positions in the most recent quarter.
Total Institutional Value
$21.72M
Total Shares Held
1,624,313
Institutional Holders
5
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $16.11M | 0.00% | New |
| 2 | STATE STREET CORP | $3.44M | 0.00% | New |
| 3 | CITADEL ADVISORS LLC | $1.47M | 0.00% | New |
| 4 | FMR LLC | $391.63K | 0.00% | New |
| 5 | Point72 Asset Management, L.P. | $303.61K | 0.00% | New |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of RNA with a position worth $16.11M, representing 0.00% of their portfolio. In total, 5 institutional investors hold RNA with a combined value of $21.72M.
In the most recent quarter, 5 funds opened a new position in RNA.
Institutional investors hold $21.72M worth of RNA stock across 5 positions. The largest institutional holder is BlackRock, Inc. with $16.11M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For RNA, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their RNA positions.